Cargando…

Trends and three-year outcomes of hepatitis C virus–viremic donor heart transplant for hepatitis C virus–seronegative recipients

OBJECTIVE: Heart transplants (HTs) from hepatitis C virus (HCV)-viremic donors to HCV-seronegative recipients (HCV D+/R–) have good 6-month outcomes, but practice uptake and long-term outcomes overall and among candidates on mechanical circulatory support (MCS) have yet to be established. METHODS: U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruck, Jessica M., Zhou, Alice L., Zeiser, Laura B., Alejo, Diane, Durand, Christine M., Massie, Allan B., Segev, Dorry L., Bush, Errol L., Kilic, Ahmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Adult: Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801334/ https://www.ncbi.nlm.nih.gov/pubmed/36590744 http://dx.doi.org/10.1016/j.xjon.2022.10.007

Ejemplares similares

Pretransplant Hepatitis C Virus Treatment Decreases Access to High-quality Livers
por: Strauss, Alexandra T., et al.
Publicado: (2021)

Uptake and 1-year outcomes of lung transplantation for COVID-19
por: Ruck, Jessica M., et al.
Publicado: (2023)

Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients
por: Axelrod, David A., et al.
Publicado: (2020)

Heart Transplant Using Hepatitis C-Seropositive and Viremic Organs in Seronegative Recipients
por: Zhu, Yuanjia, et al.
Publicado: (2020)

Kidney Transplantation From Hepatitis C Viremic Deceased Donors to Aviremic Recipients in a Real-world Setting
por: Concepcion, Beatrice P., et al.
Publicado: (2021)

Trends in Heart and Lung Transplantation in the United States Across the COVID-19 Pandemic
por: Hallett, Andrew, et al.
Publicado: (2021)

Outcomes after heart transplantation in patients who have undergone a bridge-to-bridge strategy
por: Zhou, Alice L., et al.
Publicado: (2022)

Transplantation Amid a Pandemic: The Fall and Rise of Kidney Transplantation in the United States
por: Bisen, Shivani S., et al.
Publicado: (2022)

Assessing Tissue Transmission of Hepatitis C Virus From Viremic Donor to Seronegative Kidney Transplant Recipients: A Case Series
por: Franco, Antonio, et al.
Publicado: (2023)

Successful use of a hepatitis C viremic donor in pediatric bilateral lobar lung transplantation
por: Kawashima, Mitsuaki, et al.
Publicado: (2022)

Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes
por: Cohen, Jordana B., et al.
Publicado: (2017)

Seronegative Hepatitis C Virus Infection
por: Kaźmierczak, Justyna, et al.
Publicado: (2013)

Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation
por: Reddy, Suresh, et al.
Publicado: (2018)

Patient and Graft Survival After A1/A2-incompatible Living Donor Kidney Transplantation
por: Bisen, Shivani S., et al.
Publicado: (2022)

The SHELTER Trial of Transplanting Hepatitis C Virus–Infected Lungs Into Uninfected Recipients
por: Reese, Peter P., et al.
Publicado: (2023)

Outcome of Kidney Transplants from Viremic and Non-Viremic Hepatitis C Virus Positive Donors into Negative Recipients: Results of the Spanish Registry
por: Franco, Antonio, et al.
Publicado: (2023)

Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
por: Motter, Jennifer D., et al.
Publicado: (2023)

Donation after circulatory death heart transplantation using normothermic regional perfusion:The NYU Protocol
por: James, Les, et al.
Publicado: (2022)

Right and left ventricular assist devices are an option for bridge to heart transplant
por: Barac, Yaron D., et al.
Publicado: (2022)

Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice
por: Barthold, S. W., et al.
Publicado: (1992)

Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function
por: Eisenberger, Ute, et al.
Publicado: (2018)

Functional tricuspid valve insufficiency after cardiac transplantation: Which factor is the most important?
por: Hajiyev, Vüsal, et al.
Publicado: (2020)

Prolonged waitlisting is associated with mortality in extracorporeal membrane oxygenation-supported heart transplantation candidates
por: Nordan, Taylor, et al.
Publicado: (2022)

Cardiac function unchanged following reanimation with normothermic regional perfusion in donation after circulatory death
por: Markin, Nicholas W., et al.
Publicado: (2022)

Evolving Trends in Kidney Transplant Outcomes Among Older Adults: A Comparative Analysis Before and During the COVID-19 Pandemic
por: Li, Yiting, et al.
Publicado: (2023)

Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension
por: Nguyen, Michelle C., et al.
Publicado: (2021)

Necrolytic acral erythema associated with hypothyroidism in hepatitis C virus seronegative patient
por: Baroudi, Ihsan, et al.
Publicado: (2023)

Do we really need more evidence to use hepatitis C positive donor kidney more liberally?
por: Joglekar, Kiran, et al.
Publicado: (2017)

Hepatitis D virus infection in Kermanshah, west of Iran: seroprevalence and viremic infections
por: Sayad, Babak, et al.
Publicado: (2018)

Early Results of Pilot Study Using Hepatitis C Virus (HCV) Positive Kidneys to Transplant HCV Infected Patients with End-Stage Renal Disease Allowing for Successful Interferon-Free Direct Acting Antiviral Therapy after Transplantation
por: Gallegos-Orozco, Juan F, et al.
Publicado: (2016)

Assessment of 4 Cases of Kidney Transplantation from Hepatitis C Virus Antibody-Positive and RNA-Negative Donors to Antibody-Negative Recipients
por: Unagami, Kohei, et al.
Publicado: (2016)

Assessment of hepatitis B virus pregenomic RNA in high and low viremic chronic hepatitis B patients
por: Elshayeb, Aymen Farid, et al.
Publicado: (2021)

Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions
por: Harfouche, Manale, et al.
Publicado: (2017)

Seronegative Myasthenia Gravis in Association with Human T-Lymphotropic Virus Type 1 and Hepatitis C
por: Amin, Saad Muhammad, et al.
Publicado: (2019)

Necrolytic Acral Erythema in Seronegative Hepatitis C
por: Srisuwanwattana, Ploychompoo, et al.
Publicado: (2017)

Direct-acting Antivirals for the Treatment of Kidney Transplant Patients With Chronic Hepatitis C Virus Infection in Spain: A Long-term Prospective Observational Study
por: González-Corvillo, Carmen, et al.
Publicado: (2019)

Persistence of hepatitis E virus in the liver of non-viremic naturally infected wild boar
por: Risalde, María A., et al.
Publicado: (2017)

Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation
por: Lentine, Krista L., et al.
Publicado: (2019)

Liver Transplantation for Hepatitis D Virus in the United States: A UNOS Study on Outcomes in the MELD Era
por: Kushner, Tatyana, et al.
Publicado: (2021)

Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients
por: Elefsiniotis, Ioannis S., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_5o3r222au7aj4dg4jhpna5uv0c